129 related articles for article (PubMed ID: 8684802)
1. Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients.
Jonasson F; Oshima E; Thonar EJ; Smith CF; Johannsson JH; Klintworth GK
Ophthalmology; 1996 Jul; 103(7):1111-7. PubMed ID: 8684802
[TBL] [Abstract][Full Text] [Related]
2. Macular dystrophy of the cornea. A systemic disorder of keratan sulfate metabolism.
Edward DP; Thonar EJ; Srinivasan M; Yue BJ; Tso MO
Ophthalmology; 1990 Sep; 97(9):1194-200. PubMed ID: 2234853
[TBL] [Abstract][Full Text] [Related]
3. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA
Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody.
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Haubeck HD; Küchle M; Naumann GO
Exp Eye Res; 2001 Nov; 73(5):593-600. PubMed ID: 11747360
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of macular corneal dystrophy types I and II in a single sibship.
Liu NP; Baldwin J; Lennon F; Stajich JM; Thonar EJ; Pericak-Vance MA; Klintworth GK; Vance JM
Br J Ophthalmol; 1998 Mar; 82(3):241-4. PubMed ID: 9602619
[TBL] [Abstract][Full Text] [Related]
6. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea.
Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ
Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638
[TBL] [Abstract][Full Text] [Related]
7. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy.
Hasegawa N; Torii T; Kato T; Miyajima H; Furuhata A; Nakayasu K; Kanai A; Habuchi O
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3670-7. PubMed ID: 11053262
[TBL] [Abstract][Full Text] [Related]
8. Macular corneal dystrophy types I and II are caused by distinct mutations in the CHST6 gene in Iceland.
Liu NP; Smith CF; Bowling BL; Jonasson F; Klintworth GK
Mol Vis; 2006 Oct; 12():1148-52. PubMed ID: 17093400
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Wilkins S; Cheetham ME; Wilkie SE; Hardcastle AJ; Halford S; Bayoumi AY; Ficker LA; Tuft S; Bhattacharya SS; Ebenezer ND
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):377-82. PubMed ID: 11818380
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypes of macular corneal dystrophy in India and correlation with mutations in CHST6.
Sultana A; Klintworth GK; Thonar EJ; Vemuganti GK; Kannabiran C
Mol Vis; 2009; 15():319-25. PubMed ID: 19204788
[TBL] [Abstract][Full Text] [Related]
11. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty.
Küchle M; Cursiefen C; Fischer DC; Schlötzer-Schrehardt U; Naumann GO
Arch Ophthalmol; 1999 Apr; 117(4):528-31. PubMed ID: 10206585
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I.
Lewis D; Davies Y; Nieduszynski IA; Lawrence F; Quantock AJ; Bonshek R; Fullwood NJ
Glycobiology; 2000 Mar; 10(3):305-12. PubMed ID: 10704529
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity.
Iida-Hasegawa N; Furuhata A; Hayatsu H; Murakami A; Fujiki K; Nakayasu K; Kanai A
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3272-7. PubMed ID: 12882769
[TBL] [Abstract][Full Text] [Related]
14. Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland.
Liu NP; Dew-Knight S; Rayner M; Jonasson F; Akama TO; Fukuda MN; Bao W; Gilbert JR; Vance JM; Klintworth GK
Mol Vis; 2000 Dec; 6():261-4. PubMed ID: 11139648
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic study of Egyptian patients with macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Shalaby O; Bhattacharya SS
Br J Ophthalmol; 2010 Feb; 94(2):250-5. PubMed ID: 19734134
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
[TBL] [Abstract][Full Text] [Related]
17. Sequencing of the CHST6 gene in Czech macular corneal dystrophy patients supports the evidence of a founder mutation.
Liskova P; Veraitch B; Jirsova K; Filipec M; Neuwirth A; Ebenezer ND; Hysi PG; Hardcastle AJ; Tuft SJ; Bhattacharya SS
Br J Ophthalmol; 2008 Feb; 92(2):265-7. PubMed ID: 17962390
[TBL] [Abstract][Full Text] [Related]
18. Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular corneal dystrophy.
Midura RJ; Hascall VC; MacCallum DK; Meyer RF; Thonar EJ; Hassell JR; Smith CF; Klintworth GK
J Biol Chem; 1990 Sep; 265(26):15947-55. PubMed ID: 2394754
[TBL] [Abstract][Full Text] [Related]
19. Differential immunogold localisation of sulphated and unsulphated keratan sulphate proteoglycans in normal and macular dystrophy cornea using sulphation motif-specific antibodies.
Young RD; Akama TO; Liskova P; Ebenezer ND; Allan B; Kerr B; Caterson B; Fukuda MN; Quantock AJ
Histochem Cell Biol; 2007 Jan; 127(1):115-20. PubMed ID: 16944190
[TBL] [Abstract][Full Text] [Related]
20. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
